AFME — Affluent Medical SAS Income Statement
0.000.00%
Last trade - 00:00
- €53.46m
- €62.87m
2017 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.043 | 0 | 0 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | -0.438 | — | -3.11 | -2.52 | -2.44 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.3 | 15 | 13 | 13.2 | 14.3 |
Operating Profit | -10.3 | -15 | -13 | -13.2 | -14.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.4 | -16.8 | -14.5 | -15.3 | -15.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.75 | -16.6 | -14.3 | -14.8 | -15.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.75 | -16.6 | -14.3 | -14.8 | -15.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.75 | -16.6 | -14.3 | -14.8 | -15.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.389 | -0.756 | -0.646 | -0.656 | -0.62 |
Dividends per Share |